A pooled analysis of vitamin D dose requirements for fracture prevention.

PubWeight™: 6.85‹?› | Rank: Top 1%

🔗 View Article (PMID 22762317)

Published in N Engl J Med on July 05, 2012


Heike A Bischoff-Ferrari1, Walter C Willett, Endel J Orav, Endel J Oray, Paul Lips, Pierre J Meunier, Ronan A Lyons, Leon Flicker, John Wark, Rebecca D Jackson, Jane A Cauley, Haakon E Meyer, Michael Pfeifer, Kerrie M Sanders, Hannes B Stähelin, Robert Theiler, Bess Dawson-Hughes

Author Affiliations

1: Center on Aging and Mobility, University of Zurich and Waid City Hospital, Zurich, Switzerland.

Articles citing this

(truncated to the top 100)

Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ (2014) 7.21

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (2014) 5.88

Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues? Osteoporos Int (2014) 2.74

Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41

Vitamin D--baseline status and effective dose. N Engl J Med (2012) 2.23

Vitamin D and skeletal health in infancy and childhood. Osteoporos Int (2014) 2.16

Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients (2013) 1.81

Recommendations for preventing fracture in long-term care. CMAJ (2015) 1.62

Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int (2015) 1.60

Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs. J Gen Intern Med (2016) 1.52

Trends in Dietary Supplement Use Among US Adults From 1999-2012. JAMA (2016) 1.42

Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr (2014) 1.31

Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev (2016) 1.25

The medico-legal aspects of prescribing vitamin D. Br J Clin Pharmacol (2014) 1.14

Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab (2013) 1.07

Vitamin D and cardiovascular disease. Nutrients (2013) 1.07

Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int (2012) 1.05

Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr (2013) 1.03

Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One (2013) 1.03

Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med (2014) 1.02

Recommended intakes of vitamin D to optimise health, associated circulating 25-hydroxyvitamin D concentrations, and dosing regimens to treat deficiency: workshop report and overview of current literature. J Nutr Sci (2015) 1.02

Management of cancer treatment-induced bone loss. Nat Rev Rheumatol (2013) 0.99

Vitamin D: too much of a good thing? Br J Gen Pract (2014) 0.98

Importance of frailty in patients with cardiovascular disease. Eur Heart J (2014) 0.96

Profiles of vitamin D insufficiency and deficiency in Japanese men and women: association with biological, environmental, and nutritional factors and coexisting disorders: the ROAD study. Osteoporos Int (2013) 0.96

Vitamin D and bone health: Epidemiologic studies. Bonekey Rep (2014) 0.96

Obesity and risk of hip fracture in adults: a meta-analysis of prospective cohort studies. PLoS One (2013) 0.94

1,25(OH)(2)vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells. J Steroid Biochem Mol Biol (2012) 0.94

A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures. Clin Orthop Relat Res (2016) 0.91

An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D. Mol Diagn Ther (2014) 0.91

Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health (2014) 0.90

Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci (2014) 0.90

Common misconceptions about vitamin D--implications for clinicians. Nat Rev Endocrinol (2013) 0.89

Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links. Clin Interv Aging (2013) 0.89

Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype. Kidney Int (2015) 0.89

A case study of discordant overlapping meta-analyses: vitamin d supplements and fracture. PLoS One (2014) 0.89

Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord (2013) 0.89

Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. BMC Infect Dis (2013) 0.89

Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol (2016) 0.88

Hip fractures and bone mineral density in the elderly--importance of serum 25-hydroxyvitamin D. PLoS One (2014) 0.88

Dairy in adulthood: from foods to nutrient interactions on bone and skeletal muscle health. J Am Coll Nutr (2013) 0.88

Bone Health in Athletes: The Role of Exercise, Nutrition, and Hormones. Sports Health (2016) 0.88

Before and after hip fracture, vitamin D deficiency may not be treated sufficiently. Osteoporos Int (2013) 0.87

Management of osteoporosis of the oldest old. Osteoporos Int (2014) 0.87

Vitamin D, arterial hypertension & cerebrovascular disease. Indian J Med Res (2013) 0.87

Adherence to a Mediterranean diet and risk of fractures in French older persons. Osteoporos Int (2013) 0.87

Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease. Nutrients (2013) 0.87

Vitamin D and health-related quality of life in a community sample of older Canadians. Qual Life Res (2014) 0.86

Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med (2015) 0.86

Calcium and Vitamin D Supplementations: 2015 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab (2015) 0.86

VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL). Contemp Clin Trials (2015) 0.85

Crucial Role of Vitamin D in the Musculoskeletal System. Nutrients (2016) 0.85

Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermatoendocrinol (2016) 0.85

Beneficial effects of vitamin D on falls and fractures: is cognition rather than bone or muscle behind these benefits? Osteoporos Int (2014) 0.85

Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos Int (2015) 0.84

Prospective evaluation of renal function, serum vitamin D level, and risk of fall and fracture in community-dwelling elderly subjects. Osteoporos Int (2013) 0.83

The Role of Vitamin D in the Aging Adult. J Aging Gerontol (2014) 0.83

Uremic osteoporosis. Kidney Int Suppl (2011) (2013) 0.83

Vitamin D activities for health outcomes. Ann Lab Med (2014) 0.83

Estimating the avoidable burden of certain modifiable risk factors in osteoporotic hip fracture using Generalized Impact Fraction (GIF) model in Iran. J Diabetes Metab Disord (2013) 0.83

Silicon: a review of its potential role in the prevention and treatment of postmenopausal osteoporosis. Int J Endocrinol (2013) 0.83

Vitamin D supplements with or without calcium to prevent fractures. Bonekey Rep (2014) 0.83

Vitamin D insufficiency over 5 years is associated with increased fracture risk-an observational cohort study of elderly women. Osteoporos Int (2014) 0.82

Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. PLoS One (2014) 0.82

Dietary supplements and disease prevention - a global overview. Nat Rev Endocrinol (2016) 0.81

Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions. Ther Adv Musculoskelet Dis (2013) 0.81

Live longer with vitamin D? Nutrients (2015) 0.81

Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study. BMC Med (2013) 0.81

Vitamin D metabolites and bone mineral density: The multi-ethnic study of atherosclerosis. Bone (2015) 0.81

A meta-analysis of high dose, intermittent vitamin D supplementation among older adults. PLoS One (2015) 0.81

Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. J Ren Nutr (2014) 0.80

Evaluation and treatment of osetoporotic distal radius fracture in the elderly patient. Curr Rev Musculoskelet Med (2013) 0.80

Trends in fall-related hospitalisations in older people living in aged care facilities. Osteoporos Int (2014) 0.80

The effectiveness of a preventive health program and vitamin D status in improving health-related quality of life of older Canadians. Qual Life Res (2015) 0.79

The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland. Eur J Clin Nutr (2014) 0.79

Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma. Bone Marrow Transplant (2014) 0.79

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D. Osteoporos Int (2013) 0.79

Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture. Osteoporos Int (2014) 0.79

Rising trend in vitamin D status from 1993 to 2013: dual concerns for the future. Endocr Connect (2015) 0.78

All Wales Injury Surveillance System revised: development of a population-based system to evaluate single-level and multilevel interventions. Inj Prev (2015) 0.78

Aromatase inhibitors-induced bone loss in early breast cancer. Bonekey Rep (2012) 0.78

Evaluation of fracture risk and fracture prevention: an Italian picture. Clin Cases Miner Bone Metab (2012) 0.78

Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial. Maturitas (2015) 0.78

Vitamin D status in Greenland--dermal and dietary donations. Int J Circumpolar Health (2013) 0.78

The role of vitamin D supplementation in patients with rheumatic diseases. Nat Rev Rheumatol (2013) 0.78

Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis. Yonsei Med J (2016) 0.78

Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population-based study: the Canadian Multicentre Osteoporosis Study (CaMos). J Musculoskelet Neuronal Interact (2013) 0.78

Association between promoter region genetic variants of PTH SNPs and serum 25(OH)-vitamin D level. Int J Clin Exp Pathol (2015) 0.78

Serum levels of 25-hydroxyvitamin D and the occurrence of musculoskeletal diseases: a 3-year follow-up to the road study. Osteoporos Int (2014) 0.77

Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and older. Osteoporos Int (2013) 0.77

Vitamin D levels and comorbidities in ambulatory and hospitalized patients in Austria. Wien Klin Wochenschr (2015) 0.77

Beneficial Effects of UV-Radiation: Vitamin D and beyond. Int J Environ Res Public Health (2016) 0.77

Vitamin D supplementation: less controversy, more guidance needed. F1000Res (2016) 0.77

Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients (2015) 0.77

25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies. Int J Environ Res Public Health (2017) 0.77

Poor nutritional status is associated with a higher risk of falling and fracture in elderly people living at home in France: the Three-City cohort study. Osteoporos Int (2015) 0.76

Vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 0.76

Vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 0.76

Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women. Osteoporos Int (2013) 0.76

Articles by these authors

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47

Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29

Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA (2003) 11.39

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA (2008) 8.84

Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77

Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA (2013) 7.19

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66

Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51

Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51

Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46

Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med (2005) 6.20

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95

Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (2013) 5.93

Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83

Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38

Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14

The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care (2007) 5.07

Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA (2013) 5.05

High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64

Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62

Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr (2004) 4.29

Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med (2004) 4.27

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25

Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation (2012) 4.24

Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21

Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19

Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med (2006) 4.16

The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15

Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res (2003) 4.15

A new proposed guidance system for beverage consumption in the United States. Am J Clin Nutr (2006) 4.12

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol (2007) 4.11

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07

A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology (2013) 4.06

Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03

High school dietary dairy intake and teenage acne. J Am Acad Dermatol (2005) 4.00

Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96

Association of nut consumption with total and cause-specific mortality. N Engl J Med (2013) 3.94

Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr (2009) 3.90

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88

Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) (2007) 3.86